AcornMed (金橡医学)
As one of the few leading NGS medical service companies in the industry, both solid tumors and blood tumors, AcornMed has launched more than 30 kinds of detection products, involving early diagnosis and early screening, genetic judgment, targeting and immunotherapy of multiple cancers.
69.4
69.4
NaN
NaN
NaN
NaN
Valuation
$
Valuation
Funding
$
$ 28.99 M
$ 43.49 M
Funding
$ 28.99 M
$ 43.49 M
Statistics
NA
Ventures > AcornMed (金橡医学)
AcornMed (金橡医学)
Active
Action
As one of the few leading NGS medical service companies in the industry, both solid tumors and blood tumors, AcornMed has launched more than 30 kinds of detection products, involving early diagnosis and early screening, genetic judgment, targeting and immunotherapy of multiple cancers.
- Funding
0and0